<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">Pouchitis</z:e> may complicate the construction of an ileal pouch after colectomy for <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) but not <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> (FAP) </plain></SENT>
<SENT sid="1" pm="."><plain>To examine whether differences in eicosanoid metabolism might explain why <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> is largely confined to UC patients, this study compared <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> stimulated release of immunoreactive <z:chebi fb="0" ids="15647">leukotriene B4</z:chebi> (<z:chebi fb="0" ids="15647">LTB4</z:chebi>) and <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> (<z:chebi fb="0" ids="15551">PGE2</z:chebi>) from macroscopically uninflamed pouch mucosal biopsy specimens incubated in vitro from patients with UC and FAP </plain></SENT>
<SENT sid="2" pm="."><plain>The study also compared eicosanoid release from inflamed and uninflamed pouches in patients with UC </plain></SENT>
<SENT sid="3" pm="."><plain>In uninflamed pouches, median <z:chebi fb="0" ids="15647">LTB4</z:chebi> release was nearly twice as high in UC as in FAP (p = 0.001), but there was no significant difference in <z:chebi fb="0" ids="15551">PGE2</z:chebi> production </plain></SENT>
<SENT sid="4" pm="."><plain>In UC, stimulated eicosanoid release from uninflamed functioning pouch mucosa was not significantly different from that from either ileostomy or defunctioned pouch mucosa </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="15647">LTB4</z:chebi> and <z:chebi fb="0" ids="15551">PGE2</z:chebi> release were significantly greater from inflamed than uninflamed pouch mucosa in UC (p = 0.001 and 0.01, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="25029">Leukotriene</z:chebi> synthesis inhibition or receptor antagonism, or both merit therapeutic evaluation in <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Increased release of <z:chebi fb="0" ids="15647">LTB4</z:chebi> from endoscopically <z:mpath ids='MPATH_458'>normal</z:mpath> pouch mucosa suggests increased 5-lipoxygenase activity in patients with UC and could contribute to their predisposition to <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> </plain></SENT>
</text></document>